Advertisement

Topics

J&J to pay $417m in talc cancer case

09:05 EDT 22 Aug 2017 | pharmaphorum

Johnson & Johnson has been ordered to pay $417 million to a woman claiming to have developed ovarian cancer after using its talc-based baby powder products for feminine hygiene. The verdict is a blow for J&J, which faces claims from thousa...

Original Article: J&J to pay $417m in talc cancer case

NEXT ARTICLE

More From BioPortfolio on "J&J to pay $417m in talc cancer case"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...